PATHOLOGY

SERVICES

WE PROVIDE

MDpath employs a truly end-to-end digital solution to simplify each patient’s cancer journey. Simplifying the process, improves the quality and accuracy of each diagnosis. Simplifying the workflow makes life better for the clinic, and improves the pathologist’s accuracy. MDpath utilizes new biopsy collection systems and digital workflow from LUMEA to insure that every patient receives the best care.

DIGITAL PATHOLOGY WORKING FOR YOU

MDPATH’S TISSUE HANDLING METHODS

Increase the amount of tissue available for evaluation and improve the quality of DNA for molecular testing.*

MDPATH’S DIGITAL WORKFLOW SOFTWARE

Enables clinics to conditionally order molecular tests, results in world-leading biopsy report turn around time, provides real-time clinic to sign-out specimen-tracking and visual maps of exact cancer location (core and gland).

LUMEA SOFTWARE SOLUTIONS

LEARN MORE

DIGITAL PATHOLOGY

SOLUTIONS

WATCH VIDEO

DIAGNOSTIC BIOPSY INTERPRETATION

A primary focus of Michigan Digital Pathology (MDPATH) is providing the best pathology reports to our clinics and their patients. We are passionate about the way we practice and have been for decades, which is why now, with the LUMEA platform and AI analysis we are able to provide the highest quality care in the world.

LAB MANAGEMENT SERVICES

MDPATH’s pathologists have managed labs for some of the most well-recognized hospital systems and commercial laboratories in the world. We are pioneers of the Virtual Laboratory concept, which enables clinics and small hospitals to bring digital anatomic pathology services in-house. We are the national leaders in helping our clients set up and safely run virtual pathology labs, while meeting all CLIA regulatory requirements.

MOLECULAR DIAGNOSTICS

Our pathologists are expert in setting up, validating and interpreting in-house molecular diagnostics. We are experienced in managing molecular testing for infectious disease, as well as antimicrobial sensitivity/resistance assays. We are also experienced in tumor genomic profiling, tumor characterization by FISH/ISH and Immunohistochemistry.

RESEARCH CONSULTATION

We have decades of experience working with international lab technology companies to validate and commercialize instruments, devices and most recently machine-learning algorithms. It is our goal to find the best technologies and ai-algorithms, and to apply them in our clinical practice, to benefit the patients and clinics we serve.

BIOBANKING SERVICES

MDpath, as an owner of the PathNet Lab, takes its stewardship over your patients’ tissue and data very seriously. Utilizing PathNet’s standardized consent and tissue banking protocols, clinical practices can further harness additional value from their archived tissue and data, in their own quality improvement projects, or by taking part in larger clinical trials.

*Murugan P, Shukla D, Morocho J, Smith D, Sciacca D, Pickard M, Wahlsten M, Gunderson A, Konety B, Khalifa MA, Warlick C. Prostate Biopsy Processing: An Innovative Model for Reducing Cost, Decreasing Test Time, and Improving Diagnostic Material, American Journal of Clinical Pathology, Volume 152, Issue 6, December 2019, Pages 757-756

*Wojno K, Al-Jundi R, Mazurco A, Hamzawy HA. Mp 16-19 BxChip™ Clinical tissue array increases cancer detection rate & amount of tissue available for pathologist review. The Journal of Urology. 2016; 195(4). doi:10.1016/j.juro.2016.02.2584

We’d love to work with you. Let us know how we can help.

We’d love to work with you. Let us know how we can help.

GIVE US A CALL

586.292.0848

SEND US AN EMAIL

info@mdpathlab.com

GIVE US A CALL

313.220.8403

SEND US AN EMAIL

info@mdpathlab.com